Citation Impact
Citing Papers
Structural inference of native and partially folded RNA by high-throughput contact mapping
2008 StandoutNobel
Phosphorylation and Activation of β-Adrenergic Receptor Kinase by Protein Kinase C
1995
Protein Kinase A and G Protein-coupled Receptor Kinase Phosphorylation Mediates β-1 Adrenergic Receptor Endocytosis through Different Pathways
2003 StandoutNobel
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
1997 StandoutNature
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Phosphorylation of Cell Surface Receptors: A Mechanism for Regulating Signal Transduction Pathways
1988 StandoutNobel
Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing’s syndrome in children and adolescents
2000
The molecular heterogeneity of protein kinase C and its implications for cellular regulation
1988 StandoutNature
Treatment of Cushing’s Disease: A Retrospective Clinical Study of the Latest 100 Cases
2006
Elevated late‐night salivary cortisol levels in elderly male type 2 diabetic veterans
2005
Cushing's syndrome
2015 Standout
Long‐term follow‐up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission
2002
Midnight Salivary Cortisol for the Initial Diagnosis of Cushing’s Syndrome of Various Causes
2004
Cyclic Cushing’s syndrome: a clinical challenge
2007
Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors
1997 StandoutNobel
Diagnosis of Cushing’s syndrome: Re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group
1999
NEWER DIAGNOSTIC TECHNIQUES AND PROBLEMS IN CUSHING'S DISEASE
1999
Gravin-mediated Formation of Signaling Complexes in β2-Adrenergic Receptor Desensitization and Resensitization
2000
MEDICAL THERAPY FOR CUSHING'S DISEASE
1999
Salivary cortisol for screening of Cushing's syndrome in children
1999
The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome
1994
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
2004
Regulation of receptor-mediated endocytosis by phorbol esters
1991
Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing’s disease
2006
Localization of pituitary adenomas by using intraoperative ultrasoound pituitary in patients with Cushing's disease and no demonstrable tumor on magnetic resonance imaging
1998
Nighttime Salivary Cortisol: A Useful Test for the Diagnosis of Cushing’s Syndrome
2002
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
2010 StandoutNature
A Comparison of the Use of Urinary Cortisol to Creatinine Ratios and Nocturnal Salivary Cortisol in the Evaluation of Cyclicity in Patients with Cushing's Syndrome
2012
Regulation of Membrane Targeting of the G Protein-coupled Receptor Kinase 2 by Protein Kinase A and Its Anchoring Protein AKAP79
2001 StandoutNobel
The Cushing Syndrome: An Update on Diagnostic Tests
1990
HIV infection does not require endocytosis of its receptor, CD4
1988 StandoutNobel
Urinary free cortisol versus 17-hydroxycorticosteroids a comparative study of their diagnostic value in Cushing's syndrome
1992
Detection of Adrenocorticotropin-Secreting Pituitary Adenomas by Magnetic Resonance Imaging in Children and Adolescents with Cushing Disease
2005
The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing’s Syndrome
2004
G Protein-coupled Receptors
1998 StandoutNobel
A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm
1988
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
Insulin disrupts β-adrenergic signalling to protein kinase A in adipocytes
2005 StandoutNatureNobel
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Structural basis of receptor recognition by SARS-CoV-2
2020 StandoutNature
Overnight urinary free cortisol determination: A screening test for the diagnosis of Cushing's syndrome
1998
Artifacts and limitations of enzyme immunoassay
1992
Tumour-promoting phorbol esters increase basal and inhibit insulin-stimulated lipogenesis in rat adipocytes without decreasing insulin binding
1985
Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity.
1986
Inhibition of hepatic alpha 1-adrenergic effects and binding by phorbol myristate acetate.
1985
Beta-agonist- and prostaglandin E1-induced translocation of the beta-adrenergic receptor kinase: evidence that the kinase may act on multiple adenylate cyclase-coupled receptors.
1986 StandoutNobel
The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Subunit dissociation and the inhibition of adenylate cyclase in S49 lymphoma cyc- and wild type membranes.
1984 StandoutNobel
Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors.
1992 StandoutNobel
Phorbol-ester-induced alterations of free calcium ion transients in single rat hepatocytes
1987
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
1985 StandoutNature
Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress.
1996
Phosphorylation of receptors for insulin and insulin-like growth factor I. Effects of hormones and phorbol esters.
1986
Serotonin-Mediated Endocytosis of apCAM: an Early Step of Learning-Related Synaptic Growth in Aplysia
1992 StandoutScienceNobel
Regulation of adrenergic receptor function by phosphorylation. II. Effects of agonist occupancy on phosphorylation of alpha 1- and beta 2-adrenergic receptors by protein kinase C and the cyclic AMP-dependent protein kinase.
1987 StandoutNobel
Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.
1980 StandoutNobel
Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells.
1978
Late-Night Salivary Cortisol as a Screening Test for Cushing’s Syndrome1
1998
Density-dependent regulation of growth of BSC-1 cells in cell culture: control of growth by serum factors.
1977
Hormone receptor topology and dynamics: Morphological analysis using ferritin-labeled epidermal growth factor
1979 StandoutNobel
Local starvation for epidermal growth factor cannot explain density-dependent inhibition of normal human glial cells.
1977
CD45, an integral membrane protein tyrosine phosphatase. Characterization of enzyme activity.
1990 StandoutNobel
Increasing the cAMP content of IM-9 cells alters the phosphorylation state and protein kinase activity of the insulin receptor.
1986
Phorbol esters inhibit alpha1 adrenergic stimulation of glycogenolysis in isolated rat hepatocytes
1984
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes.
1985 StandoutNobel
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells
1976 StandoutNatureNobel
Regulation of transmembrane signaling by receptor phosphorylation
1987 StandoutNobel
Biochemical and Radiologic Diagnosis of Cushing’s Syndrome
1994
Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its C-terminal, cytoplasmic domain.
1986
Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism.
1985 StandoutNobel
Regulation of adrenergic receptor function by phosphorylation. I. Agonist-promoted desensitization and phosphorylation of alpha 1-adrenergic receptors coupled to inositol phospholipid metabolism in DDT1 MF-2 smooth muscle cells.
1987 StandoutNobel
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Member‐associated changes during erythropoiesis. On the mechanism of maturation of reticulocytes to erythrocytes
1981
Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies.
1995
The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc
1996 StandoutScience
Binding, internalization, and degradation of epidermal growth factor by Balb 3T3 and BP3T3 cells: Relationship to cell density and the stimulation of cell proliferation
1979
Iron metabolism-new perspectives in view
1992
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
1997
Phorbol esters inhibit alpha 1-adrenergic effects and decrease the affinity of liver cell alpha 1-adrenergic receptors for (-)-epinephrine.
1986
Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes.
1986
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
1998
Insulin- and phorbol ester-stimulated phosphorylation of ribosomal protein S6.
1985
The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors
1983 StandoutNobel
Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence
1985 StandoutNobel
Identification of lymphocyte integral membrane proteins as substrates for protein kinase C. Phosphorylation of the interleukin-2 receptor, class I HLA antigens, and T200 glycoprotein.
1986
Differential effects of phorbol ester on phenylephrine and vasopressin-induced Ca2+ mobilization in isolated hepatocytes.
1985
Decreased binding of epidermal growth factor to BALB/c 3T3 mutant cells defective in glycoprotein synthesis
1978 Nature
Controlling mRNA lifespan
1988 StandoutNatureNobel
Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells
1978
Guanine nucleotide activation and inhibition of adenylate cyclase as modified by islet-activating protein, pertussis toxin, in mouse 3T3 fibroblasts
1983
Transit of receptors for epidermal growth factor and transferrin through clathrin-coated pits. Analysis of the kinetics of receptor entry.
1985
Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
1988 Science
Association of phorbol ester-induced hyperphosphorylation and reversible regulation of transferrin membrane receptors in HL60 cells.
1984
Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells.
1990 StandoutNobel
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
Quantitative determination of the lateral diffusion coefficients of the hormone-receptor complexes of insulin and epidermal growth factor on the plasma membrane of cultured fibroblasts.
1978
Iron-Sulfur Clusters: Nature's Modular, Multipurpose Structures
1997 StandoutScience
Light-dependent phosphorylation of rhodopsin by β-adrenergic receptor kinase
1986 StandoutNatureNobel
Ubiquitin Aldehyde Increases Adenosine Triphosphate–Dependent Proteolysis of Hemoglobin α-Subunits in β-Thalassemic Hemolysates
1997
Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.
1978 StandoutNobel
Photochemically generated cytosolic calcium pulses and their detection by fluo-3
1989 StandoutNobel
Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor.
1986 StandoutNobel
Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C.
1983
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
1984 StandoutNature
Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors
1979 Nature
Induction of expression and phosphorylation of the human interleukin 2 receptor by a phorbol diester.
1984
The insulin receptor
1984
Mechanism of phorbol diester-induced regulation of surface transferrin receptor involves the action of activated protein kinase C and an intact cytoskeleton.
1985
Diagnosis and Management of Cushing's Syndrome: Results of an Italian Multicentre Study
1999
Epidermal Growth Factor
1979 StandoutNobel
A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles.
1982 StandoutNobel
Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells.
1985
Vascular wall growth control: the role of the endothelium.
1981
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor.
1979 StandoutNobel
Pituitary Magnetic Resonance Imaging Findings Do Not Influence Surgical Outcome in Adrenocorticotropin-Secreting Microadenomas
2004
ADP Receptors on Platelets
1996
Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors.
1985
The Changes in Plasma Cortisol and Urinary Free Cortisol by an Overnight Dexamethasone Suppression Test in Patients with Cushing's Disease.
1988
Phorbolesters enhance basal D-glucose transport but inhibit insulin stimulation of D-glucose transport and insulin binding in isolated rat adipocytes
1985
Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells
1979
Works of P Thomopoulos being referenced
Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome
1996
Protein kinase C potentiates isoproterenol‐mediated cyclic AMP production without modifying the homologous desensitization process in J774 cells
1987
Long-distance and long-term follow-up of a patient with intermittent Cushing's disease by salivary cortisol measurements
1995
Evening urinary free corticoids: a screening test in Cushing's syndrome and incidentally discovered adrenal tumours
1988
False Hyperthyrotropinemia Induced by Heterophilic Antibodies against Rabbit Serum
1981
Durable remission of Cushing's disease after OP'DDD treatment
1982
ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3.
1995
Excess alpha chains are lost from beta-thalassemic reticulocytes by proteolysis.
1981
Effect of phorbol esters on iron uptake in human hematopoietic cell lines.
1984
Hemin regulates the expression of transferrin receptors in human hematopoietic cell lines
1982
Urinary free corticoids: an evaluation of their usefulness in the diagnosis of Cushing's syndrome
1983
[Magnetic resonance imaging in Cushing disease. Prediction of surgical results].
1997
Studies on the regulation of insulin receptors in cultured BALB/3T3 fibroblasts
1978
Embryonic and fetal hemoglobin synthesis in K562 cell line.
1981
Insulin receptors in normal and transformed fibroblasts: relationship to growth and transformation
1976
Cyclic AMP increases the concentration of insulin receptors in cultured fibroblasts and lymphocytes
1977
Expression of transferrin receptors in phytohemagglutinin-stimulated human T-lymphocytes. Evidence for a three-step model.
1986
Inhibition of Insulin Receptor Binding by Phorbol Esters
1982
Inhibition of transferrin binding and iron uptake of hematopoietic cell lines by phorbol esters
1984
Loss of insulin receptors on maturation of reticulocytes
1978
Effect of ATP and ADP on U-937 Promonocyte Cell Adhesiveness and Intracellular Ca++Levels
1991
Phorbol esters inhibit the binding of low‐density lipoproteins (LDL) to U‐937 monocytelike cells
1984